Spero Therapeutics

Scroll
Investment area
Novo Seeds
Region
Eastern USA
Date of investment
June 2019
Website
http://www.sperotherapeutics.com/

Spero Therapeutics is a global, multi-asset, clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. Our mission is to become a leader in the field of Gram-negative antibiotics and we aim to achieve this objective by advancing multiple, differentiated products towards commercialization in key territories.